Indoco
Rajib Mallick is a seasoned professional with extensive experience in the pharmaceutical sector, currently serving as Senior Vice President and Vertical Head of Acute Business at Indoco Remedies Ltd. since February 2024. Prior to this role, Rajib held senior leadership positions at Akumentis Healthcare Ltd. and Corona Remedies Pvt Ltd., with a notable tenure at Alkem Laboratories Ltd. as Vice President overseeing Sales and Marketing operations for its Acute division, focusing on Anti-infective and GI Therapy. Rajib's career began at Torrent Pharmaceuticals Ltd., where responsibilities included top line management and strategic planning. Rajib holds a PGDM in Personnel Management and Industrial Relations from the Institute of Productivity and Management and a Bachelor of Science in Physics.
Indoco
Indoco Remedies Limited is an India-based company, which is engaged in the manufacture of pharmaceutical products. The Company primarily manufactures and markets Formulations (Finished Dosage Forms) and Active Pharmaceutical Ingredients (APIs). The Company's geographical segments include India and Outside India. It offers products for various therapeutic categories, such as stomatologicals, respiratory, anti-infectives, gastrointestinal, pain/analgesics, gynecological, vitamins/minerals/nutrients, ophthal/otologicals and dermatology. Its domestic marketing divisions include INDOCO, SPADE, Warren NxGen, Warren Ace, Spera, Indoco Focus, Indoco CND, Warren Excel, Warren Vision, Eterna, Institution and Indoco IMPULSE. The Company's products include Sensodent-K, Homide, Carmicide, Renolen, Rexidin M, Febrex Plus, Zincoren, Otorex, Cloben G, Methycal, Tuspel, Scabex, Hemsyl, Karvol Plus, Durashape, Lignox, Sensoform Toothpaste, Kidodent Toothpaste, Rosuchek D, Otichek and Irimist.